ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. The great quarter was driven by high ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...

ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst ...

(RTTNews) - Resmed Inc (RMD) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The company's earnings totaled $344.6 million, or $2.34 per share.

Sleep device giant ResMed expects to benefit from Donald Trump’s trade tariffs and tax cuts if competitors making rival products in China and Mexico are slapped with additional duties when they ...

There is a need to address the rising cases of sleep apnea in India. (Image Credits: Pixabay) ResMed on Tuesday announced that it has launched AirSense 11 in India. According to the company’s ...

MANILA, Philippines — Kapamilya actress Jodi Sta. Maria announced that she's planning to take a break from showbiz to pursue further education. During the finale press conference of her ABS-CBN ...

has granted the company Special Temporary Authority (STA) authorizing testing service in the United States. This approval enables AST SpaceMobile’s first five commercial BlueBird satellites ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

Related reads:PC vs SEC: Check our Fantasy Cricket Prediction, Tips, Playing Team Picks for SA20 2025, Match 7 on January 14th In the derby clash, Melbourne Renegades will take on Melbourne Stars ...